3D medical animation still shot, showing the structure of the coronavirus. Credit: Scientific Animations.

Enzo Biochem has introduced Covid-19 test kits under the US FDA’s emergency use authorisation (EUA) authority.

The tests were introduced as part of the company’s comprehensive Covid-19 programme.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Enzo Biochem Covid-19 test kits include a collection system, sample preparation, sample processing and detection products, as well as molecular analytic capabilities.

Additionally, the company said that the test uses in-house diagnostics technology to improve scale, throughput and sensitivity along with more relevant positive control materials.

RNAseP, Enzo’s control, confirms the presence of human mucosa cells in the specimen. This ensures accurate collections.

Enzo CEO Dr Elazar Rabbani said: “Enzo is uniquely positioned to address the Covid-19 pandemic from multiple angles. We have an open molecular diagnostic system with complete capabilities from sample collection to processing, detection and analytics.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“Our open system allows for adaptability with regards to reagents, supplies and instruments. This system can be used for the current Covid-19 crisis, and furthermore, it can be repurposed for any current or future infectious agent diagnosis.

“Our solutions are available as full system product sales or as individual components.”

Overall, the company’s comprehensive Covid- 19 Program includes its molecular diagnostic virus screening products, IgG / IgM serological ELISA products to determine immunity and ELISA platform to detect inflammation.

The programme also features a proprietary drug candidate (SK1-I).

With the test, Enzo Biochem seeks to address the current challenges faced by the healthcare industry, including supply shortages.

In the US, there are more than 869,000 confirmed cases of coronavirus. Globally, the number has reached 2.7 million.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact